UBX: Unity Biotechnology, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 21.23
Enterprise Value ($M) 12.33
Book Value ($M) 14.14
Book Value / Share 0.84
Price / Book 1.50
NCAV ($M) -2.73
NCAV / Share -0.16
Price / NCAV -7.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.57
Return on Assets (ROA) -0.32
Return on Equity (ROE) -0.60

Liquidity (mrq)
Quick Ratio 3.45
Current Ratio 3.45

Balance Sheet (mrq) ($M)
Current Assets 30.26
Assets 47.13
Liabilities 32.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2 days ago 13G/A Alyeska Investment Group, L.P. 9.99 -0.53

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 13,589 48,498 28.02
2024-11-14 20,812 55,572 37.45
2024-11-13 10,023 59,729 16.78
2024-11-12 14,243 95,977 14.84
2024-11-11 16,263 140,382 11.58

(click for more detail)

Similar Companies
TWST – Twist Bioscience Corporation TXMD – TherapeuticsMD, Inc.
TYRA – Tyra Biosciences, Inc. UTHR – United Therapeutics Corporation
VERV – Verve Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io